These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 11221019)

  • 1. Irinotecan in combined-modality therapy for locally advanced non-small-cell lung cancer.
    Choy H; MacRae R
    Oncology (Williston Park); 2001 Jan; 15(1 Suppl 1):31-6. PubMed ID: 11221019
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Topoisomerase I inhibitors in the combined-modality therapy of lung cancer.
    Cho LC; Choy H
    Oncology (Williston Park); 2004 Jun; 18(7 Suppl 4):29-39. PubMed ID: 15255165
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Irinotecan and radiation in combined-modality therapy for solid tumors.
    Choy H; MacRae R
    Oncology (Williston Park); 2001 Jul; 15(7 Suppl 8):22-8. PubMed ID: 11497228
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Irinotecan in combination with radiation therapy for small-cell and non-small-cell lung cancer.
    Wu HG; Choy H
    Oncology (Williston Park); 2002 Sep; 16(9 Suppl 9):13-8. PubMed ID: 12375796
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Topoisomerase I inhibitors in the combined modality therapy of lung cancer.
    Choy H; Kim JS; Pyo H; MacRae R
    Clin Lung Cancer; 2001 May; 2 Suppl 2():S34-40. PubMed ID: 14725728
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Irinotecan in advanced lung cancer: focus on North American trials.
    Langer CJ
    Oncology (Williston Park); 2004 Jun; 18(7 Suppl 4):17-28. PubMed ID: 15255164
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Weekly irinotecan and concurrent radiation therapy for stage III unresectable NSCLC.
    Choy H; Chakravarthy A; Devore RF; Jagasia M; Hande KR; Roberts JR; Johnson DH; Yunus F
    Oncology (Williston Park); 2000 Jul; 14(7 Suppl 5):43-6. PubMed ID: 10981290
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current status of irinotecan in lung cancer.
    Fukuoka M
    Oncology (Williston Park); 2001 Jan; 15(1 Suppl 1):6-7. PubMed ID: 11221022
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current role of irinotecan in the treatment of non-small-cell lung cancer.
    Kelly K
    Oncology (Williston Park); 2002 Sep; 16(9):1153-62, 1165; discussion 1165-6 passim. PubMed ID: 12380945
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Irinotecan in small-cell lung cancer: the US experience.
    Sandler AB
    Oncology (Williston Park); 2001 Jan; 15(1 Suppl 1):11-2. PubMed ID: 11221015
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Docetaxel and irinotecan, alone and in combination, in the treatment of non-small cell lung cancer.
    Adjei AA; Argiris A; Murren JR
    Semin Oncol; 1999 Oct; 26(5 Suppl 16):32-40; discussion 41-2. PubMed ID: 10585007
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Irinotecan: summary and future directions.
    Johnson DH
    Oncology (Williston Park); 2001 Jan; 15(1 Suppl 1):46-7. PubMed ID: 11221021
    [No Abstract]   [Full Text] [Related]  

  • 13. Role of topoisomerase I inhibitors in small-cell lung cancer.
    Fukuoka M
    Oncology (Williston Park); 2001 Jul; 15(7 Suppl 8):9-13. PubMed ID: 11497234
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phase I/II study of weekly irinotecan and concurrent radiation therapy for locally advanced non-small cell lung cancer.
    Takeda K; Negoro S; Kudoh S; Okishio K; Masuda N; Takada M; Tanaka M; Nakajima T; Tada T; Fukuoka M
    Br J Cancer; 1999 Mar; 79(9-10):1462-7. PubMed ID: 10188891
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of non-small-cell lung cancer in North America: the emerging role of irinotecan.
    Langer CJ
    Oncology (Williston Park); 2001 Jan; 15(1 Suppl 1):19-24. PubMed ID: 11221017
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Chemotherapy for non-small cell lung cancer].
    Shinkai T; Saijo N
    Nihon Kyobu Shikkan Gakkai Zasshi; 1996 Dec; 34 Suppl():92-8. PubMed ID: 9216193
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Irinotecan plus cisplatin in patients with advanced non-small-cell lung cancer.
    Devore R; Johnson D; Crawford J; Dimery I; Eckardt J; Eckhardt SG
    Oncology (Williston Park); 1998 Aug; 12(8 Suppl 6):79-83. PubMed ID: 9726097
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Irinotecan in the management of patients with pancreatic cancer.
    Green MR; Harper M; Safa A; Sherman CA; Mushtaq CM; Bahadori H; Brescia FJ; Rocha Lima CM
    Oncology (Williston Park); 2000 Dec; 14(12 Suppl 14):31-3. PubMed ID: 11200146
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CPT-11: an original spectrum of clinical activity.
    Rothenberg ML
    Semin Oncol; 1996 Feb; 23(1 Suppl 3):21-6. PubMed ID: 8633249
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Establishment of the standard regimen for non-small-cell lung cancer in Japan.
    Masuda N
    Oncology (Williston Park); 2001 Jan; 15(1 Suppl 1):13-8. PubMed ID: 11221016
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.